Live feed16:15:14·1hINSIDERFilingvia QuantisnowChief Commercial Officer Hopman Mark sold $619,640 worth of shares (30,779 units at $20.13) as part of a pre-agreed trading plan, decreasing direct ownership by 35% to 56,479 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.BBNX· Beta Bionics Inc.Health CareOriginal source